CymitQuimica logo
COX

COX

Les inhibiteurs de la cyclooxygénase (COX) sont des composés qui bloquent l'activité des enzymes COX, impliquées dans la production de prostaglandines, des médiateurs clés de l'inflammation et de la douleur. En neurosciences, les inhibiteurs de la COX sont étudiés pour leur potentiel à réduire la neuroinflammation, qui est impliquée dans diverses maladies neurodégénératives telles que la maladie d'Alzheimer, la maladie de Parkinson et la sclérose en plaques. En inhibant la COX, ces composés peuvent aider à atténuer les processus inflammatoires dans le cerveau et à protéger contre les lésions neuronales. Chez CymitQuimica, nous fournissons une gamme d'inhibiteurs de la COX pour soutenir vos recherches sur la neuroinflammation, la gestion de la douleur et les maladies neurodégénératives.

562 produits trouvés pour "COX"

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
produits par page.
  • Soquelitinib

    CAS :
    <p>Soquelitinib (CPI-818) is a selective ITK inhibitor, inhibits tumor growth,T-cell, up-regulatCXCR3, IFNγ, TNFα, and CD107a expression in normal CD8 cells.</p>
    Formule :C25H30N4O4S2
    Degré de pureté :99.54%
    Couleur et forme :Solid
    Masse moléculaire :514.66
  • NLRP3-IN-69

    CAS :
    <p>NLRP3-IN-69 (Compound 23) inhibits the activation of NF-κBp65 and the formation of the NLRP3 inflammasome. It suppresses the overexpression of IL-1β, iNOS, and COX-2 induced by LPS, and inhibits the production of NO (IC50=5.66 μM), thereby demonstrating anti-inflammatory activity.</p>
    Formule :C25H24O7
    Couleur et forme :Solid
    Masse moléculaire :436.454
  • Anti-inflammatory agent 10


    <p>Tilomisole-derived benzimidazole-thiazole, orally active, favors COX-2 inhibition over COX-1.</p>
    Formule :C17H13BrN4O3S2
    Couleur et forme :Solid
    Masse moléculaire :465.34
  • STAT1/3-IN-1

    CAS :
    <p>STAT1/3-IN-1 (Compound 6k) is an inhibitor of STAT1/3 phosphorylation. It prevents the phosphorylation and nuclear translocation of STAT1/3. Additionally, STAT1/3-IN-1 inhibits the inflammatory enzymes iNOS and COX-2. This compound exhibits anti-inflammatory properties by reducing pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, without significant cytotoxicity.</p>
    Formule :C28H25ClN6O5
    Couleur et forme :Solid
    Masse moléculaire :560.988
  • XO/COX/LOX-IN-1


    <p>XO/COX/LOX-IN-1 targets XO/COX/LOX, used in research of inflammation, cancer, and metabolic disorders.</p>
    Formule :C24H20N4O2S
    Couleur et forme :Solid
    Masse moléculaire :428.51
  • COX-2-IN-6

    CAS :
    <p>COX-2-IN-6: Potent, selective COX-2 inhibitor; oral; IC50 0.84μM, Ki 69nM; blocks PGE2 synthesis; prevents colorectal cancer.</p>
    Formule :C20H27NO6S
    Degré de pureté :99.29% - 99.69%
    Couleur et forme :Soild
    Masse moléculaire :409.5
  • COX-1/2-IN-2


    <p>COX-1/2-IN-2, a potent dual inhibitor, has IC50s: COX-1 at 9.7μM &amp; COX-2 at 4.6μM.</p>
    Formule :C15H10ClIN2O
    Couleur et forme :Solid
    Masse moléculaire :396.61
  • COX-2-IN-29


    <p>COX-2-IN-29 is a selective inhibitor of orally active COX-2 (IC50: 0.005 μM).</p>
    Formule :C22H23FN2O6S2
    Couleur et forme :Solid
    Masse moléculaire :494.56
  • (R)-Ketoprofen

    CAS :
    <p>(R)-Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) that exhibits oral activity and analgesic properties. Unlike its counterpart, (R)-Ketoprofen does not significantly enhance the increase of inflammatory cytokines (such as Tumor Necrosis Factor (TNF) and Interleukin-1 (IL-1)) induced by LPS. However, it can inhibit the anti-inflammatory activity of (S)-Ketoprofen.</p>
    Formule :C16H14O3
    Couleur et forme :Solid
    Masse moléculaire :254.28
  • Ambuic acid

    CAS :
    <p>Ambuic acid: cyclohexanone with antifungal, quorum-inhibiting, antibacterial properties, blocks cyclic peptides; reduces MRSA abscesses in mice.</p>
    Formule :C19H26O6
    Couleur et forme :Solid
    Masse moléculaire :350.41
  • COX-2-IN-7


    <p>COX-2-IN-7: potent, orally active COX-2 inhibitor with higher selectivity than Celecoxib, IC50 6.585 uM, anti-inflammatory, low ulcer risk.</p>
    Formule :C15H13N3O2S2
    Couleur et forme :Solid
    Masse moléculaire :331.41
  • Sabialimon P

    CAS :
    <p>Sabialimon P (compound 16), with an IC50 of 18.12 μM, functions as a NO release inhibitor and exhibits anti-inflammatory properties. It effectively diminishes the secretion of TNF-α, iNOS, IL-6, and NF-κB, and suppresses the expression of COX-2 and NF-κB/p65 in LPS-induced RAW264.7 cells.</p>
    Formule :C31H50O4
    Couleur et forme :Solid
    Masse moléculaire :486.73
  • Neral

    CAS :
    <p>Neral, a monoterpenoid compound, exhibits anti-inflammatory and anticancer activities. It inhibits TNF-α and IL-6, along with inflammatory mediators such as pro-IL-1β, iNOS, COX-2, and NLRP-3.</p>
    Formule :C10H16O
    Couleur et forme :Solid
    Masse moléculaire :152.23
  • COX-2-IN-51

    CAS :
    <p>COX-2-IN-51 (E25) is a potent COX-2 inhibitor with an IC50 of 70.7 nM. It significantly suppresses LPS-induced release of NO and PGE2, the expression of COX-2 and iNOS, and the activation of the NF-κB pathway. Displaying anti-inflammatory and analgesic effects in various mouse models through NF-κB pathway inhibition, COX-2-IN-51 has lower gastrointestinal side effects compared to Indomethacin.</p>
    Formule :C23H18F4O3S
    Couleur et forme :Solid
    Masse moléculaire :450.446
  • COX-2/15-LOX-IN-5

    CAS :
    <p>COX-2/15-LOX-IN-5 (Compound 4f) functions as a dual inhibitor of COX-2 and 15-LOX, demonstrating both anti-inflammatory and antioxidant properties [1]. This compound effectively reduces NF-κB activation in RAW 264.7 macrophages that is induced by lipopolysaccharide.</p>
    Formule :C25H21N3O3S
    Couleur et forme :Solid
    Masse moléculaire :443.52
  • COX-2/NO-IN-1


    <p>COX-2/NO-IN-1: oral iNOS &amp; NO blocker (IC50=3.52μM), COX-2 supressor, anti-inflammatory, protects kidneys.</p>
    Formule :C15H15NO3
    Couleur et forme :Solid
    Masse moléculaire :257.28
  • COX-2-IN-47

    CAS :
    <p>COX-2-IN-47 (compound 6c) is a selective inhibitor of COX-2, exhibiting an IC50 of 0.03 μM. This compound also displays antiedema activity.</p>
    Formule :C18H18N2O4
    Couleur et forme :Solid
    Masse moléculaire :326.35
  • COX-2/PI3K-IN-2


    <p>COX-2/PI3K-IN-2 (5f): anti-inflammatory &amp; anti-cancer, selectively inhibits COX-2 (Ki=3.02nM), potently blocks PI3K (IC50=2.78nM).</p>
    Formule :C16H17N5O2
    Couleur et forme :Solid
    Masse moléculaire :311.34
  • COX-2/PI3K-IN-1


    <p>COX-2/PI3K-IN-1 (compound 5d) is a potent inhibitor of PI3K (IC50: 1.14 nM). COX-2/PI3K-IN-1 is a selective inhibitor of COX-2 (Ki: 3.24 nM).</p>
    Formule :C19H14ClN5S2
    Couleur et forme :Solid
    Masse moléculaire :411.93
  • COX-2-IN-9


    <p>COX-2-IN-9: potent oral COX-2 blocker, selective over Celecoxib, IC50 10.17 μM, less ulcers, strong anti-inflammatory.</p>
    Formule :C25H23N5O4S2
    Couleur et forme :Solid
    Masse moléculaire :521.61